combination therapy with glp-1 receptor agonist and sglt2 inhibitor & – Bolt Pharmacy GLP-1 receptor agonists and SGLT2

Trial titration schedules (both peptides) Semaglutide escalation in CagriSema trials: Cagrilintide escalation in CagriSema trials: Combined timeline: Important timing note: Cagrilintide reaches target dose week 13 Semaglutide reaches target dose week 17 4-week stagger reduces side effect peak Both at maximum by week 17 See our cagrilintide and semaglutide combination overview and semaglutide dosage calculator

Its known to assist with fat burning and metabolism, as well as helping to regulate appetite and sleep patterns

Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H

E., Shataeva, L

We take strict steps to avoid these issues